However, there is evidence suggesting that the unaffected tissue areas of IBD undergo an abnormal immune activation as shown by the expression of increased levels of the proinflammatory cytokines IL-6, TNFα [4], and IL-18, in intestinal biopsies from CD patients [5]. The gene discussed is TNF; the disease is inflammatory bowel disease.